K. Tryfonidis

Pembrolizumab Plus Chemotherapy Followed by Pembrolizumab in Patients With Early Triple-Negative Breast Cancer

V. Karantza, H. Iwata, H. Mukai, 2023, JAMA network open.

A Narrative Review of the Clinical, Humanistic, and Economic Value of Pembrolizumab-Based Immunotherapy for the Treatment of Breast and Gynecologic Cancers

V. Karantza, G. Aktan, V. Prabhu, 2024, Oncology and therapy.